Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Regulation of Opioid Receptor Activities

Ping-Yee Law and Horace H. Loh
Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 607-624;
Ping-Yee Law
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Horace H. Loh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

From the demonstration of the existence of multiple opioid receptors and the isolation of the endogenous opioid peptides in the brain, it is now clear that the activities of these receptors can be regulated at various levels. The distinct brain regional distribution of the receptor suggests a tight transcriptional regulation. Early findings of alterations in receptor binding associated with tolerance to the opioids implies that the receptor life cycle can be influenced by the presence of agonists. Until the recent reported cloning of opioid receptors, the detailed studies of the molecular mechanisms involved in their regulation could not be conducted. With the availability of the cDNA clones of the μ-, δ- and κ-opioid receptors, and the elucidation of their gene structures, it is now possible to investigate opioid receptor regulation at various levels, and to identify the specific receptors involved in the pharmacological actions of the opioids. It is now also possible to define the receptor domains responsible for the opioid ligand selectivities, agonist activation, and agonist-induced inactivation. Summarized in this report are our past efforts in defining the regulation of opioid receptor activities. Studies using heterologous expression techniques, mutational analysis of receptors to characterize transcriptional elements, and the in vivo manipulation of the receptor gene levels have made it is possible to determine the mechanisms whereby these receptors are regulated. Our studies have also identified the unique characteristics of opioid receptors as members of the superfamily of G protein-coupled receptors.

Footnotes

  • Send reprint requests to: Horace H. Loh, Department of Pharmacology, 3-249 Millard Hall, University of Minnesota Medical School, 435 Delaware St. S.E., Minneapolis, MN 55455-0347. E-mail:lohxx001{at}maroon.tc.umn.edu

  • ↵1 This study was supported by National Institutes of Health Grants DA11806, DA00564, DA01583, DA07339, DA70554, and the A. and F. Stark Fund of the Minnesota Medical Foundation.

  • Abbreviations:
    GPCR
    G protein-coupled receptors
    CHO
    Chinese hamster ovary
    DAMGO
    [d-Ala2,N-MePhe4,Gly-ol5]
    DPDPE
    [d-Pen2,d-Pen5]-enkephalin
    Tippψ
    H-Tyr-Tic[ψ,CH2NH]Phe-Phe-OH (Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid)
    CTOP
    d-Phe-Cys-Tyr-d-Trp-Orn-Thr-Pen-Thr-NH2
    TM6
    transmembrane domain 6
    EL
    extracellular loop
    NTB
    naltriben
    IL
    intracellular loop
    GRK
    G protein-coupled receptor kinase
    PKA
    protein kinase A
    PKC
    protein kinase C
    PTX
    pertussis toxin
    IBMX
    3-isobutyl-1-methylxanthine
    GIRK
    G protein-coupled voltage-dependent inward rectifying potassium channels
    RACE
    rapid amplification of cDNA ends
    M6G
    morphine-6-glucuronide
    TIS
    transcription initiation sites
    AP
    activator protein
    NF
    nuclear factor
    NGFI-B
    nerve growth factor-induced transcription activator
    • Received February 19, 1999.
    • Accepted March 3, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 289 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 289, Issue 2
1 May 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Regulation of Opioid Receptor Activities
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Regulation of Opioid Receptor Activities

Ping-Yee Law and Horace H. Loh
Journal of Pharmacology and Experimental Therapeutics May 1, 1999, 289 (2) 607-624;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Regulation of Opioid Receptor Activities

Ping-Yee Law and Horace H. Loh
Journal of Pharmacology and Experimental Therapeutics May 1, 1999, 289 (2) 607-624;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • A Sincere Thanks
    • Introduction
    • Differences in μ- and δ-Opioid Receptor Signal Transduction
    • Differential Regulation of μ- and δ-Opioid Receptor Signal Cascades at Level of Ligand-Receptor Interaction
    • Differential Regulation of μ- and δ-Opioid Receptor at G Protein Level
    • Regulation of μ- and δ-Opioid Receptor Levels by Phosphorylation and Down-Regulation
    • Regulation of Opioid Receptor Activities by Associating Proteins
    • Regulation of Opioid Receptor at Transcriptional Level
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Antagonism of Immunostimulatory CpG-Oligodeoxynucleotides by 4-Aminoquinolines and Other Weak Bases: Mechanistic Studies
  • Pharmacodynamics of Immunosuppression by Mycophenolic Acid: Inhibition of Both Lymphocyte Proliferation and Activation Correlates with Pharmacokinetics
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics